Serina Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | |
| 89.1% | 80.8% | 42.7% | 34.9% | 90.4% | 40.1% | 38.4% | 102.2% | 20.1% | 80.0% | 74.5% | 53.8% | 77.9% | 97.6% | 96.8% | 121.8% | 64.3% | 124.3% | 141.7% | 1,700.0% | 680.0% | 325.0% | 422.2% | 425.0% | 43.3% | 257.1% | 182.8% | 0.2% | 500.0% | 111.8% | 17,250.0% | – | – | 12.3% | – | – | – | – | – | |
| 10.9% | 19.2% | 57.3% | 65.1% | 9.6% | 59.9% | 61.6% | -2.2% | -20.1% | 20.0% | 25.5% | 46.2% | 22.1% | 2.4% | 3.2% | -21.8% | 35.7% | -24.3% | -41.7% | -1,600.0% | -580.0% | -225.0% | -322.2% | -325.0% | 56.7% | -157.1% | -82.8% | 99.8% | -400.0% | -11.8% | -17,150.0% | – | – | 87.7% | – | – | – | – | – | |
| 578.3% | 377.2% | 377.5% | 253.5% | 620.9% | 275.2% | 318.2% | 441.9% | 427.5% | 397.4% | 318.0% | 242.3% | 284.1% | 292.5% | 161.1% | 207.1% | 519.6% | 1,210.8% | 1,012.5% | 17,150.0% | 7,260.0% | 1,883.3% | 1,433.3% | 2,187.5% | 1,330.0% | 6,842.9% | 1,896.6% | 29.4% | 22,120.0% | 3,125.5% | 17,250.0% | – | – | 2,424.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7,412.5% | 1,976.7% | 6,757.1% | 3,065.5% | 62.8% | 24,400.0% | 4,554.9% | 20,792.9% | – | – | 1,956.2% | – | – | – | – | – | |
| 1,085.4% | 701.3% | 569.2% | 405.2% | 1,160.7% | 519.8% | 642.1% | 1,070.6% | 1,101.3% | 925.8% | 823.4% | 540.9% | 642.5% | 636.5% | 557.1% | 462.8% | 4,130.4% | 5,935.1% | 6,933.3% | 93,000.0% | 40,460.0% | 13,033.3% | 16,900.0% | 21,950.0% | 3,263.3% | 13,342.9% | 4,962.1% | 92.0% | 46,020.0% | 7,580.4% | 20,792.9% | – | – | 4,368.5% | – | – | – | – | – | |
| -1,074.5% | -682.1% | -511.9% | -340.2% | -1,151.0% | -459.9% | -580.5% | -1,072.8% | -1,121.4% | -905.8% | -797.8% | -494.7% | -620.4% | -634.1% | -553.9% | -484.6% | -4,094.6% | -5,959.5% | -6,975.0% | -94,600.0% | -41,040.0% | -13,258.3% | -17,222.2% | -22,275.0% | -3,206.7% | -13,500.0% | -5,044.8% | 7.8% | -46,420.0% | -7,580.4% | -37,942.9% | – | – | -4,280.8% | – | – | – | – | – | |
| 6.7% | 5.0% | – | – | – | – | – | – | – | – | – | 4.4% | 10.1% | 21.0% | 34.3% | 41.8% | 433.9% | 740.5% | 1,187.5% | 14,750.0% | 22,300.0% | 7,191.7% | 10,255.6% | 12,225.0% | 286.7% | 1,542.9% | 344.8% | 5.7% | 1,980.0% | 474.5% | 114.3% | – | – | 6.9% | – | – | – | – | – | |
| -1,033.7% | -106.6% | -533.4% | -337.1% | -134.3% | -420.5% | -575.0% | -1,046.0% | -1,002.6% | -829.5% | -784.2% | -496.0% | -625.6% | -659.7% | -591.0% | -516.4% | -3,558.9% | -6,689.2% | -8,145.8% | -107,950.0% | -54,140.0% | -21,816.7% | -27,066.7% | -34,512.5% | 5,526.7% | 11,542.9% | 6,041.4% | 34.0% | -300,300.0% | 10,151.0% | 9,878.6% | – | – | -4,970.8% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 23.3% | 0.8% | 13.1% | 3.3% | – | – | – | -29.7% | – | -2.7% | – | -50.0% | -20.0% | -8.3% | -11.1% | -725.0% | -26.7% | -142.9% | 41.4% | -0.1% | 1,980.0% | -52.9% | – | – | – | – | – | – | – | – | – | |
| -937.1% | -204.3% | -518.3% | -329.0% | -98.3% | -415.9% | -566.1% | -1,017.9% | -1,001.0% | -812.9% | -783.7% | -493.8% | -618.8% | -649.5% | -585.9% | -484.4% | -3,728.6% | -6,686.5% | -8,145.8% | -107,900.0% | -54,120.0% | -21,816.7% | -27,055.6% | -33,787.5% | 5,526.7% | 11,542.9% | 6,041.4% | 34.0% | -300,300.0% | 10,203.9% | 10,071.4% | – | – | -4,960.0% | – | – | – | – | – | |
| -947.6% | -603.3% | -505.3% | -309.8% | -83.3% | -395.3% | -537.6% | -998.1% | -1,078.9% | -763.4% | -721.7% | -438.1% | -544.3% | -549.8% | -471.4% | -360.4% | -3,066.1% | -5,870.3% | -6,841.7% | -91,550.0% | -31,180.0% | -14,350.0% | -16,444.4% | -21,862.5% | 5,856.7% | 13,328.6% | 6,569.0% | 39.9% | -296,080.0% | 10,737.3% | 10,392.9% | – | – | -4,951.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.